Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$2.24M Buy
67,930
+842
+1% +$25.8K 0.1% 176
2014
Q4
$1.79M Sell
67,088
-1,690
-2% -$43.6K 0.08% 192
2014
Q3
$1.67M Sell
68,778
-1,990
-3% -$50.3K 0.08% 194
2014
Q2
$1.79M Buy
70,768
+6,050
+9% +$141K 0.09% 190
2014
Q1
$1.39M Sell
64,718
-2,365
-4% -$51K 0.07% 210
2013
Q4
$1.5M Buy
67,083
+2,963
+5% +$65.3K 0.07% 199
2013
Q3
$1.32M Buy
64,120
+225
+0.4% +$4.79K 0.07% 208
2013
Q2
$1.23M Buy
+63,895
New +$1.33M 0.07% 206

Other funds holding HOLX

Boston Private Bank & Trust's HOLX Position: Q1 2015 in Review

Boston Private Bank & Trust increased its Hologic (HOLX) stake by 1.3% in Q1 2015, buying an estimated $25.8K and bringing the position to 67,930 shares worth $2.24M. The position accounts for 0.1% of the portfolio, ranked #176.

Boston Private Bank & Trust first reported a position in HOLX in Q2 2013 and has held it in 8 quarters since. 393 funds tracked by Wall St. Rank hold HOLX as of Q1 2015.

  • Boston Private Bank & Trust held 67,930 shares of Hologic worth $2.24M as of Q1 2015.
  • Boston Private Bank & Trust bought 842 Hologic shares in Q1 2015, an estimated $25.8K.
  • Hologic made up 0.1% of Boston Private Bank & Trust's portfolio in Q1 2015, its #176 holding.
  • Boston Private Bank & Trust first reported a position in Hologic in Q2 2013 and has held it in 8 quarters since.
  • 393 funds tracked by Wall St. Rank held Hologic as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.